DEL BELLO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.277
EU - Europa 7.190
AS - Asia 6.228
SA - Sud America 747
Continente sconosciuto - Info sul continente non disponibili 568
AF - Africa 256
OC - Oceania 54
Totale 31.320
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.691
CN - Cina 2.388
SG - Singapore 1.819
IT - Italia 1.707
RU - Federazione Russa 1.535
DE - Germania 941
PL - Polonia 712
BR - Brasile 599
VN - Vietnam 536
HK - Hong Kong 504
CA - Canada 428
GB - Regno Unito 402
UA - Ucraina 369
FR - Francia 365
SE - Svezia 320
FI - Finlandia 311
ZA - Sudafrica 175
TR - Turchia 170
KR - Corea 155
IN - India 148
IE - Irlanda 117
BD - Bangladesh 111
JP - Giappone 91
CZ - Repubblica Ceca 82
MX - Messico 69
NL - Olanda 68
BE - Belgio 60
PK - Pakistan 54
AR - Argentina 51
AU - Australia 51
ES - Italia 48
EU - Europa 38
IQ - Iraq 35
IR - Iran 32
EG - Egitto 28
ID - Indonesia 28
AT - Austria 23
EC - Ecuador 23
MY - Malesia 21
SA - Arabia Saudita 17
CO - Colombia 16
PT - Portogallo 16
UY - Uruguay 15
CR - Costa Rica 14
HR - Croazia 14
PH - Filippine 14
VE - Venezuela 14
LT - Lituania 13
AE - Emirati Arabi Uniti 12
JM - Giamaica 12
PE - Perù 12
CH - Svizzera 11
GT - Guatemala 11
RO - Romania 11
TW - Taiwan 11
KE - Kenya 10
NP - Nepal 10
BY - Bielorussia 9
CL - Cile 9
HN - Honduras 9
HU - Ungheria 9
IL - Israele 9
GR - Grecia 8
MA - Marocco 8
NI - Nicaragua 8
RS - Serbia 8
UZ - Uzbekistan 8
DK - Danimarca 7
TT - Trinidad e Tobago 7
AL - Albania 6
AZ - Azerbaigian 6
GP - Guadalupe 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
SV - El Salvador 6
TH - Thailandia 6
TN - Tunisia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DZ - Algeria 5
JO - Giordania 5
LV - Lettonia 5
PR - Porto Rico 5
PY - Paraguay 5
KH - Cambogia 4
NG - Nigeria 4
QA - Qatar 4
SN - Senegal 4
DO - Repubblica Dominicana 3
GE - Georgia 3
GH - Ghana 3
LK - Sri Lanka 3
OM - Oman 3
PA - Panama 3
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
Totale 30.763
Salva come PNG Salva come JPEG
Città #
Ashburn 1.377
Dallas 1.331
Singapore 955
Fairfield 925
San Jose 898
Jacksonville 870
Woodbridge 820
Chandler 602
Warsaw 579
Council Bluffs 564
Houston 530
Ann Arbor 518
Hong Kong 483
Wilmington 464
Boardman 427
Beijing 423
Seattle 376
Camerino 353
Cambridge 293
New York 278
Nanjing 275
Los Angeles 256
Toronto 247
Dearborn 203
Ho Chi Minh City 177
Helsinki 166
Johannesburg 158
The Dalles 157
Santa Clara 149
Seoul 144
San Mateo 140
Tongling 139
Princeton 138
Lawrence 133
Istanbul 123
Hanoi 122
Lauterbourg 122
Columbus 117
Dublin 117
Kraków 113
Munich 111
Nanchang 104
Orem 103
Buffalo 101
Milan 98
London 96
Ogden 96
Moscow 95
Phoenix 95
Düsseldorf 93
Shanghai 77
Tokyo 71
Chicago 70
Shenyang 67
São Paulo 65
Guangzhou 64
Rome 64
Jiaxing 57
Kunming 57
Brno 56
Brussels 52
Frankfurt am Main 52
Trieste 51
Lachine 50
Jinan 49
San Diego 48
Tianjin 48
Turku 47
Chennai 46
Washington 45
Changsha 41
Manchester 41
Hebei 39
Montreal 39
Bremen 38
Brooklyn 38
Philadelphia 38
St Louis 37
Centro 36
Denver 36
Atlanta 35
Hangzhou 33
Zhengzhou 33
Ascoli Piceno 31
Mexico City 31
Stockholm 30
Dong Ket 29
Redondo Beach 29
Wuhan 29
Da Nang 27
Poplar 27
Redwood City 27
Nuremberg 26
Perugia 25
Venezia 25
Ningbo 24
Amsterdam 23
Haiphong 23
Hefei 22
Salt Lake City 22
Totale 19.324
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 671
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 649
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 640
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 580
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 541
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 475
1,4-Dioxane Nucleus as a Suitable Scaffold for the Characterization of Different Receptor Systems 419
An Efficient Lewis Acid Catalyzed Povarov Reaction for the One-Pot Stereocontrolled Synthesis of Polyfunctionalized Tetrahydroquinolines 355
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 349
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 341
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 341
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 337
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 332
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 322
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation 310
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 310
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine 307
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 306
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 304
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 280
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 277
Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms 274
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 270
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 265
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 259
Biguanide derivatives as surfactants and antimicrobial agents for pharmaceutical applications 258
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 256
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 252
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 251
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 249
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 243
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 236
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 236
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 235
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 231
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 230
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 229
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 228
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 226
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders 224
Adenosine receptors as promising targets for the management of ocular diseases 223
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 221
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 220
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 220
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 219
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 216
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 216
New insights in Au-NHCs complexes as anticancer agents 215
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 214
BIOLOGICAL PROFILE AND BIOAVAILABILITY OF IMIDAZOLINE COMPOUNDS AFFECT THEIR MODULATORY ACTIVITY ON MORPHINE TOLERANCE 213
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 212
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 211
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 209
4WD to Travel Inside the 5-HT1A Receptor World 208
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 206
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 206
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 205
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 205
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 204
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 203
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 203
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 202
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 201
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 200
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 200
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 200
Effects of imidazoline I2 receptor ligands on acute nociception in rats 199
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 198
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 198
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 197
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 197
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 196
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 192
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 190
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma 187
Effects of allyphenyline on chronic alcohol intoxication model 187
Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility 186
Activation of primary amines by copper(I)-based Lewis acid promoters in the solventless synthesis of secondary propargylamines 186
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 185
Efficient Lewis Acid Systems for the A3 Coupling reaction 185
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 184
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 182
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 182
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 181
Trekking through receptor chemistry 177
Imidazoline nucleus as a biologically versatile scaffold 176
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 175
Design, synthesis, reactivity, biological and catalytic applications of functionalized bis(pyrazolyl)acetate copper complexes 174
Hybrid molecules from xanomeline and 77-LH-28-1 as potential novel M1 muscarinic agonists 172
Chemistry and antitumor investigations of new Cu(I) complexes of bis(pyrazol-1-yl)acetate ligands functionalized with an NMDA receptor antagonist 164
NOVEL IMIDAZOLINE MOLECULES INSPIRED BY THE PHARMACOLOGICAL PROFILE OF AGMATINE AS POTENTIAL TOOLS IN MANAGING OPIOID ADDICTION 162
A Versatile Continuous Fluorometric Enzymatic Assay for Targeting Nicotinate Phosphoribosyltransferase 158
Synthesis, reactivity and biological studies of bioconjugated bis(pyrazolyl)acetate copper complexes 157
Aminopyrimidines as inhibitors of the Wnt signalling pathway 156
Design and synthesis of novel imidazoline derivatives potentially targeting dopamine receptors 153
Molecular determinants in the binding of novel 1,4-benzodioxan-related α1D-adrenergic receptor antagonists: a computational study 153
Novel muscarinic antagonists designed on the 1,4-dioxane scaffold 153
Structural motives of imidazoline molecules favouring the serotonin 5-HT1A receptor activation 153
Novel antitumor Cu(I) and Cu(II) complexes based on bioconjugate ligands rationally designed to act through synergistic mechanisms 153
Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel alpha1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and alpha1d computational study 148
Totale 24.546
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022909 0 0 0 58 93 63 46 111 122 165 85 166
2022/20231.867 232 71 89 237 186 214 20 118 360 106 152 82
2023/20241.608 195 94 131 52 68 175 76 57 159 62 43 496
2024/20255.106 241 110 424 246 192 265 602 1.166 433 324 333 770
2025/20269.019 490 574 1.601 1.180 804 577 1.237 603 511 590 550 302
2026/20272.600 710 276 700 914 0 0 0 0 0 0 0 0
Totale 31.320